A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Status:
Completed
Trial end date:
2019-12-23
Target enrollment:
Participant gender:
Summary
A Randomized,Open-label, Single-Dose,Two-Cycle,Cross- Bioequivalence Study of Doxorubicin
Hydrochloride Liposome Injection Under Advanced Breast Cancers.